Vicore Pharma Holding AB
STO:VICO

Watchlist Manager
Vicore Pharma Holding AB Logo
Vicore Pharma Holding AB
STO:VICO
Watchlist
Price: 7.76 SEK 0.78% Market Closed
Market Cap: 1.8B SEK
Have any thoughts about
Vicore Pharma Holding AB?
Write Note

Vicore Pharma Holding AB
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vicore Pharma Holding AB
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Vicore Pharma Holding AB
STO:VICO
Gross Profit
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Gross Profit
kr950.2m
CAGR 3-Years
20%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Gross Profit
kr752.8m
CAGR 3-Years
60%
CAGR 5-Years
46%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Gross Profit
kr2.1B
CAGR 3-Years
27%
CAGR 5-Years
18%
CAGR 10-Years
20%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Gross Profit
kr20B
CAGR 3-Years
19%
CAGR 5-Years
17%
CAGR 10-Years
30%
BioArctic AB
STO:BIOA B
Gross Profit
kr565.1m
CAGR 3-Years
144%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
No Stocks Found

Vicore Pharma Holding AB
Glance View

Market Cap
1.8B SEK
Industry
Biotechnology

Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. The company is headquartered in Goeteborg, Vastra Gotalands. The company went IPO on 2015-12-10. The firm's portfolio contains small molecules with potential indications, including anti-inflammation, nerve generation and cardiovascular disease. The firm is a wholly owned subsidiary of Mintage Scientific AB.

VICO Intrinsic Value
2.86 SEK
Overvaluation 63%
Intrinsic Value
Price

See Also

Back to Top